Physician-Administered Therapies: Access Strategies & Insights

Revisit our recorded webinar to hear more about the expected evolution of the access and reimbursement environment for physician-administered therapies, and an outline what it means for you as you prepare to launch physician-administered therapies.

During this session, we share data and discuss:

• Payer management of physician-administered therapies today, including their desire and ability to manage medical therapy utilization and spend in various therapeutic areas
• Expected evolution in payer management of physician-administered therapies to achieve their objectives across various TAs including, immunology, oncology, rare diseases, next gen curative therapies
• Expected avenues to achieve their objective e.g. Medical Rebate / Value Based Contracts, Color Bagging, Alternative Payment Models
• What it means to manufacturers as they develop their market access strategies and prepare to launch physician-administered therapies
• How Ipsos can help – Introducing our V5 framework to help brand teams develop their patient access strategies